| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | CN1063439C N-substituted 2-hetero cyclicbutanol |
| 03/20/2001 | US6204293 Inhibitors of protein isoprenyl transferases |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/20/2001 | US6204221 For controlling weeds in crops |
| 03/20/2001 | CA2071529C Diaromatic substituted anti-aids compounds |
| 03/15/2001 | WO2001017992A1 Inhibitors of prenyl-protein transferase |
| 03/15/2001 | WO2001017985A1 Novel derivatives of flavones, xanthones and coumarins |
| 03/15/2001 | WO2001017984A1 Chalcone coumarins |
| 03/15/2001 | WO2001017982A1 Benzophenones as inhibitors of reverse transcriptase |
| 03/15/2001 | WO2001017975A1 Pyrimidine derivatives and herbicides containing the same |
| 03/15/2001 | WO2001017974A1 Process for preparing a 1-substituted 5-hydroxymethyl imidazole |
| 03/15/2001 | WO2001017968A1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 03/15/2001 | WO2001017965A2 Cyanopiperidines as pesticides |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2001017530A1 Iron chelators and uses thereof |
| 03/15/2001 | WO2000075127A8 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof |
| 03/15/2001 | WO2000053583A8 Inhibitors of protein tyrosine phosphatase |
| 03/15/2001 | WO1999065870A3 Sulfonamide inhibitors of aspartyl protease |
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | CA2383782A1 Compounds for the treatment of viral infections |
| 03/15/2001 | CA2383721A1 Use of 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogues as iron chelators |
| 03/15/2001 | CA2382861A1 Process for preparing a 1-substituted 5-hydroxymethyl imidazole |
| 03/15/2001 | CA2382112A1 Chalcone coumarins |
| 03/14/2001 | EP1083175A2 Triazole derivatives having antifungal activity |
| 03/14/2001 | EP1082439A2 Recombinant narbonolide polyketide synthase |
| 03/14/2001 | EP1082321A1 Heterocyclic derivatives which inhibit factor xa |
| 03/14/2001 | EP1082308A1 Heterocyclically substituted amides used as calpain inhibitors |
| 03/14/2001 | EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 03/14/2001 | EP0682664B1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 03/14/2001 | CN1063176C Chromone derivative |
| 03/13/2001 | US6201132 Inhibitors of membrane-bound serine protease; aminoacyl compounds |
| 03/13/2001 | US6201013 Inosine monophosphate dehydrogenase (impdh) inhibitor; side effect reduction, non-drug resistant |
| 03/13/2001 | US6201007 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
| 03/13/2001 | US6201006 Aromatic amidine derivatives useful as selective thrombin inhibitors |
| 03/13/2001 | US6201003 Insecticides, miticides, aphidicides, anthelmintics for crops, veterinary medicine, horticulture and agriculture |
| 03/13/2001 | US6200995 Pyridyloxybenzenesulfonamide derivatives; diabetes, obesity |
| 03/13/2001 | US6200993 Heterosubstituted pyridine derivatives as PDE4 inhibitors |
| 03/13/2001 | US6200992 Administering 1h-1,2,4-triazole derivative, chemotherapeutic agent, and potentiator; anticarcinogenic, antitumor agents |
| 03/13/2001 | US6200990 4-phenylpiperidin-1-ylethanol derivatives; vision defects, brain and spinal cord injuries |
| 03/13/2001 | US6200989 Administering as urokinase plasminogen activator antagonists, antitumor and antimetastasis agents |
| 03/13/2001 | US6200987 Cyclic amides |
| 03/13/2001 | US6200979 Administering substituted pyrazoles and pyzazolopyrimidines for treating phobias obsessive-compulsive disorder, post-traumatic stress disorder, single episode depression, recurrent depression, dysthymia, bipolar disorders |
| 03/13/2001 | CA2021328C Stereoselective preparation of z-1,2-diarylallyl chlorides and the conversion thereof into azolylmethyloxiranes and novel intermediates |
| 03/08/2001 | WO2001016138A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 03/08/2001 | WO2001016131A2 Five membered-ring compounds and utilization thereof in liquid crystal mixtures |
| 03/08/2001 | WO2001016127A1 Chromone derivatives, process for the preparation of the same and uses thereof |
| 03/08/2001 | WO2001016123A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | WO2001016122A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | WO2001016121A1 Heterocyclic compounds and methods of use thereof |
| 03/08/2001 | WO2001016108A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 03/08/2001 | WO2001016103A1 Fused pyrrolecarboxamides: gaba brain receptor ligands |
| 03/08/2001 | WO2001015656A2 Tricyclic compounds and their uses as antiarrhythmic antifibrillatory and defibrillatory agents |
| 03/08/2001 | WO2000078751A3 Compounds for use in treatment of neurological disorders |
| 03/08/2001 | WO2000059506A8 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 03/08/2001 | WO2000057861A3 Use of cytidine derivatives for the treatment of leukaemia |
| 03/08/2001 | WO2000038786A3 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/08/2001 | WO1999058526A8 Novel 2,5-pyridinedicarboxylic acid derivatives |
| 03/08/2001 | WO1999019296A8 Aminobutanoic acid derivatives |
| 03/08/2001 | DE19941649A1 New fluorothiophene, furan, isoxazole, thiazole, cyclopentane, cyclopentene and alkylfluorothiophenecarboxylic acid compounds are useful in liquid crystals mixtures and synthesis of liquid crystals, agrochemicals and pharmaceuticals |
| 03/08/2001 | CA2384435A1 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 03/08/2001 | CA2384194A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | CA2383347A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | CA2381553A1 Fused pyrrolecarboxamides: gaba brain receptor ligands |
| 03/08/2001 | CA2379421A1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 03/07/2001 | EP1081148A2 Enantiomerically pure beta-D-dioxolane-nucleosides |
| 03/07/2001 | EP1081146A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081144A2 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081143A1 Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems |
| 03/07/2001 | EP1081138A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 03/07/2001 | EP1081132A1 Hydroxamic acid derivatives and medicinal utilization thereof |
| 03/07/2001 | EP1079830A1 BENZIMIDAZOLE ANALOGS AS DOWN-REGULATORS OF IgE |
| 03/07/2001 | EP1079825A2 Compounds that inhibit the binding of integrins to their receptors |
| 03/07/2001 | EP1079821A1 Protease inhibitors |
| 03/07/2001 | EP0934295B1 Novel bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in cosmetics |
| 03/07/2001 | EP0915935B1 4,7-dichlororhodamine dyes |
| 03/07/2001 | EP0836594B1 Benzylhydroxylamines and intermediates used to prepare them |
| 03/07/2001 | EP0832083B1 Microbicidal (mercapto-triazolyl methyl)-dioxacycloalkanes |
| 03/07/2001 | EP0730579B1 Substituted indoles as phosphodiesterase type iv inhibitors |
| 03/07/2001 | CN1286690A Compounds useful for inhibition of farnesyl protein transferase |
| 03/07/2001 | CN1286686A Taxane derivs |
| 03/07/2001 | CN1286684A Carboxamide derivs. of pyrrolidine, piperidine and hexahydroazepine for treatment of thrombosis disorders |
| 03/07/2001 | CN1286683A Tetrahydrobenzindole derivs |
| 03/07/2001 | CN1286254A Aromatic amino ether as analgesics |
| 03/07/2001 | CN1286251A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1286250A Method for preparing 5-lipooxygenase inhibitor having changeable heterocycle system |
| 03/07/2001 | CN1062865C Process for production of amidinobenzofuran and amidinobenzothiophen derivs. and salt thereof |
| 03/06/2001 | US6197975 7-azabicyclo(2.2.1)heptane-7-carbonyl-substituted 2-phenylindole derivatives; sexual disorders; anticarcinogenic agents |
| 03/06/2001 | US6197973 Herbicides |
| 03/06/2001 | US6197972 Chemical intermediates for anticholesterol agents |
| 03/06/2001 | US6197958 Carboxylic acid derivatives, their preparation and use |
| 03/06/2001 | US6197782 Therapy for sexual disorders |
| 03/06/2001 | US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 03/06/2001 | US6197772 1- (1,2-disubstituted piperidinyl) -4-substituted piperazine derivatives |
| 03/06/2001 | US6197225 Chromene compound |
| 03/01/2001 | WO2001014879A1 4-unsubstituted dihydroisoquinolinone derivatives and combinatorial libraries thereof |
| 03/01/2001 | WO2001014376A1 Novel spiro compounds |